search
SLS
Trends
- 1
Brazilian skateboarder Rayssa Leal is competing at the Street League Skateboarding event in Paris, and attention is on her ahead of the contest. Estadão published the full schedule, times and where to watch the event live, as fans in Brazil look for how to follow her performance.
- 2Stock Futures Climb Ahead of AMD Results as Palantir Rally Continues▼Nasdaq, S&P 500 Futures Climb As Wall Street Awaits AMD, SpaceX Earnings After Palantir Rally: Why SNAP, AMZN, SNDK, LCID, SLS, ASTS Are In Focus
Nasdaq and S&P 500 futures are rising as Wall Street awaits earnings from AMD and SpaceX following a strong Palantir rally. Traders are also watching SNAP, Amazon, SanDisk, Lucid, Sls and AST SpaceMobile, with several stocks in focus for further moves after recent gains in tech and space-related names.
- 3SLS and IBRX climb as Moderna joins Nasdaq-100▼SLS, IBRX Stocks Climb Overnight: Retail Eyes Moderna’s Rally As MRNA Lands A Nasdaq-100 Spot
SLS and IBRX shares rose in overnight trading while retail investors turned their attention to Moderna after the biotech was added to the Nasdaq-100 index. Traders are watching whether Moderna's inclusion sparks a broader rally in biotech names, with retail chatter focused on momentum across MRNA and related small-cap stocks heading into the next session.
- 4Retail Traders Eye SLS and IBRX After Moderna Joins Nasdaq-100●SLS, IBRX Stocks Draw Retail Chatter As MRNA Lands A Nasdaq-100 Spot – ‘It Will Be SLS Next’
Retail investors are buzzing about small-cap biotech stocks Sellas Life Sciences (SLS) and ImmunityBio (IBRX) after Moderna (MRNA) earned a spot in the Nasdaq-100 index. Traders are speculating that one of these smaller biotechs could be the next index addition, with some betting 'it will be SLS next' as index inclusion typically brings fund inflows and a share price boost.
- 5Retail biotech favorites SLS, IBRX, VNDA, IOVA vs September slump▼Biotech Lagged The Broader Market In September — Did Retail Favorites SLS, IBRX, VNDA And IOVA Dodge XBI’s Slump?
Biotech stocks lagged the broader market in September, with the SPDR S&P Biotech ETF (XBI) falling while the wider market held up better. Attention is now on whether retail-favored names SELLAS Life Sciences (SLS), ImmunityBio (IBRX), Vanda Pharmaceuticals (VNDA) and Iovance Biotherapeutics (IOVA) managed to escape the sector's slump. Investors are weighing whether these popular small-cap biotechs diverged from the wider sector weakness.
- 6Sellas Shares End Three-Quarter Winning Streak●SLS Stock Snaps 3-Quarter Winning Streak — Why Retail Traders Are Watching Sellas’ Lease And AML Pipeline
Sellas Life Sciences shares have broken a three-quarter run of gains, drawing attention from retail traders. Discussion is centered on the company's lease situation and its pipeline of AML-focused drug candidates, which investors see as key to whether the stock can resume its climb after the streak-ending pullback.
- 7Japanese cram school says autumn of second high school year decides med school success●https://www. gotorola.com/553101/ 【高2の秋が勝負】医学部合格者が語る「受かる高2生」と「危ない高2生」の決定的な違い # 2次試験 # Entertainment # march # UCXErsls7Y
A Japanese university-prep cram school, Takeda Juku, is telling students that the autumn of their second year of high school is the decisive period for medical school admissions, outlining the difference between students likely to pass and those at risk. Successful medical school entrants share study methods, advice on the common test and secondary exams, and tips for national and top private universities like Keio and Waseda.